Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

02:31 EST 21st February 2017 | BioPortfolio

Showing News Articles 1–25 of 810,000+

Tuesday 21st February 2017

TelaDoc Inc TDOC Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryTelaDoc Inc Teladoc is a healthcare service provider that provides telehealth services to the healthcare market. The company offers short term prescription for Amoxicillin, Azithromycin, Bactrim DS, Augmentin, Cipro, Tessalon Perles, Flonase Nasal Spray, Pyridium, Prednisone and Diflucan. It provides telehealth services for cold and flu symptoms, bronchitis, allergies, poison ivy, pink eye,...

Intellia Therapeutics Inc NTLA Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryIntellia Therapeutics Inc Intellia Therapeutics is a genome editing company that develops curative therapeutics utilizing CRISPR/Cas9, a biological tool. The company develops in vivo programs focused on liver diseases including transthyretin amyloidosis, alpha1 antitrypsin deficiency, hepatitis b virus and inborn errors of metabolism; and ex vivo programs focused on chimeric antigen recepto...

Micromem Technologies Inc MRM Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryMicromem Technologies Inc Micromem is a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, oil well sensor solutions, energy storage solutions, and others. Micromem provides nanoscale fracking sensors, m...

Tyrian Diagnostics Ltd TDX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryTyrian Diagnostics Ltd Tyrian Diagnostics formerly Proteome Systems Ltd is a medical equipment company that manufactures, and markets diagnostics for clinical and nonclinical applications. The company discovers and validates novel biomarkers for tuberculosis. It has developed a proprietary point of care diagnostics platform such as diagnostiQTM. Tyrian also develops various solutions for pr...

Concordia International Corp CXR Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryConcordia International Corp Concordia, formerly Concordia Healthcare Corp is a pharmaceutical company that offers orphan drugs. The company undertakes the management and acquisition of legacy pharmaceutical products, orphan drugs and medical devices for diabetics. Its product portfolio comprises Orapred, Donnatal, Ulesfia, Zonegran, Dibenzyline, Dutoprol, Dyrenium, Fortaz, Kayexalate, Lano...

Glenmark Pharmaceuticals Ltd GLENMARK Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryGlenmark Pharmaceuticals Ltd Glenmark manufactures and markets formulations, generics and active pharmaceutical ingredients. The company focuses on the discovery of NCEs new chemical entities and NBEs new biological entities. Its product pipeline comprises of seven molecules in various stages of clinical and preclinical development, which are being developed for the treatment of respiratory...

Oncolytics Biotech Inc ONC Financial and Strategic SWOT Analysis Review [Updated: 08022017] Prices from USD $125

Oncolytics Biotech Inc ONC Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment...

Sirtex Medical Ltd SRX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummarySirtex Medical Ltd Sirtex Medical is a life science company that develops and markets device for oncology treatment. The company's sirspheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors that contains radioactive yttrium90. Its microspheres are injected into the main artery, which supplies liver tumors. Sirtex Medical offers microsp...

Syngene International Ltd SYNGENE Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummarySyngene International Ltd Syngene a subsidiary of Biocon Ltd is a contract research organization that provides integrated services. The organization offers drug discovery and development services that include lead generation and optimization, medicinal chemistry, toxicology, custom synthesis, in vivo pharmacology, process research and development, cGMP manufacturing, formulations and clinic...

Production of taxadiene by engineering of mevalonate pathway in Escherichia coli and endophytic fungus Alternaria alternata TPF6

Taxol (paclitaxel) is a diterpenoid compound with significant and extensive applications in the treatment of cancer. The production of Taxol and relevant intermediates by engineered microbes is an attractive alternative to the semichemical synthesis of Taxol. In this study, based on a previously developed platform, we first established taxadiene production in mutant E. coli T2 and T4 by engineerin...

Auris Medical Holding AG EARS Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAuris Medical Holding AG Auris Medical is a pharmaceutical company that develops pharmaceutical therapies to protect hearing and to silence tinnitus. The company's product pipeline comprise of AM101, AM111, AM102 and AM123. It operates two projects, AM101 for the treatment of tinnitus, and AM111 for the treatment of acute sensorineural hearing loss. The company also offers treatment for inn...

Opto Circuits India Limited OPTOCIRCUI Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryOpto Circuits India Limited Opto Circuits is a medical device company that designs, develops, manufactures, markets and distributes medical equipment and devices for healthcare practices. The company's medical equipment includes vital signs patient monitors, respiratory and anesthetic care products, data management and connectivity, PAD devices, defibrillation, veterinary care products, sen...

Seeing DNA 'blink'

Many of the secrets of cancer and other diseases lie in the cell's nucleus. But getting way down to that level -- to see and investigate the important genetic material housed there -- requires creative thinking and extremely powerful imaging techniques. Vadim Backman and Hao Zhang, nanoscale imaging...

Cosmo Bio Co Ltd 3386 Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryCosmo Bio Co Ltd Cosmo Bio is a medical device company that develops and markets research reagents and research instruments. The company provides reagents, research instruments and life science research biotools for biochemistry, such as sugars, lipids, lectins, hormones, peptides, amino acids and chemical substances. It offers reagents, kits, instruments, diagnostics, and software. Cosmo B...

Global Epilepsy Partnering 2010 to 2017 [Updated: 01022017] Prices from USD $1495

The Global Epilepsy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and ag...

Cantabio Pharmaceuticals Inc CTBO Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryCantabio Pharmaceuticals Inc Cantabio Pharmaceuticals focuses on the commercializing of novel therapies for Parkinson's disease, Alzheimer's disease and other related neurodegenerative diseases. It pipeline product candidates include CB101 and CB102, used to treat Parkinson's disease; CB201 is being developing for the treatment of Parkinson's disease and Alzheimer's disease and CB301, is u...

OBJ Ltd OBJ Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryOBJ Ltd OBJ is a developer of magnetic microarray and powerless drug delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and precommercialisation support. It also provides IP opportunities, technology design evaluations and market exclusivi...

ASLAN Pharma Initiates Enrollment for HER-2 Cancer Drug Phase I Study in Japan

ASLAN Pharma of Singapore is initiating enrollment of the first patient in the Phase I clinical trial for varlitinib (ASLAN001) in biliary tract cancer in Japan. The study is expected to enroll up to 36 Japanese patients. Designed in collaboration with Japanese medical experts, the open-label study is open to all patients with solid tumours and biliary tract cancer. The primary study objectiv...

Hutchison MediTech Begins Phase II Study of Its PSC Drug Savolitinib in China

Hutchison China MediTech (Chi-Med) and AstraZeneca have launched a Phase II study in China of savolitinib (HMPL-504/AZD6094/volitinib), an oral inhibitor targeting c-Met receptor tyrosine kinase for treatment of locally advanced or metastatic pulmonary sarcomatoid carcinoma (PSC). The first drug dose was administered on February 10, 2017. More details....Stock Symbols (AIM/Nasdaq: HCM)  ...

Lee's Pharm to Market Solasia's Oral Mucositis Treatment in China

Lee’s Pharm acquired Greater China commercialization rights to episil®, a treatment for oral mucositis, from Japan's Solasia Pharma. The agreement does not include Taiwan nor the cities of Beijing, Shanghai or Guangzhou, which Solasia will retain. episil®, an oral liquid that treats the pain associated with oral mucositis, was developed by Camurus of Sweden. Solasia in-licensed right...

Hamilton Thorne Ltd HTL Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryHamilton Thorne Ltd Hamilton Thorne is a medical device company that designs, manufactures and distributes precision laser devices and advanced image analysis systems. The company offers products, which include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm analyzer options, sperm analysis accessories, IMSIstrict and oo...

Vanda Pharmaceuticals Inc VNDA Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryVanda Pharmaceuticals Inc Vanda Pharmaceuticals is a biopharmaceutical company that develops and commercializes pharmaceutical products for treating central nervous system disorders. The company provides Hetlioz tasimelteon for the treatment of non24hour sleepwake disorder in the US, and filed MAA for the product in Europe. It also offers Fanapt, an atypical antipsychotic for the treatment ...

Monday 20th February 2017

Vention Medical to divest advanced technology and device manufacturing businesses

Vention Medical has agreed to divest its advanced technology business to Nordson and device manufacturing services business to Medplast.

Akers Biosciences, Inc. AKER Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAkers Biosciences, Inc. ABI is a medical device company that develops, manufactures and supplies in vitro diagnostic technologies. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tricholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone....

Symphogen AS Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250

SummarySymphogen A/S Symphogen develops recombinant antibody mixtures, which can be used in the production of nextgeneration antibody therapeutics for the treatment of cancer, infectious and autoimmune diseases. It develops antibody therapeutics based on its three proprietary technology platforms such as Symplex discovery, SymSelect functional and Sympress technology. Symphogen's product pipeline ...


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.